Company strength

R&D

The company is committed to the first imitation and rapid imitation of major and multiple diseases clinically urgent varieties, in cardiovascular, diabetes and other important therapeutic areas to establish a product group, and continue to increase investment to strengthen the accumulation of technology and products; At the same time, the company continues to improve the accumulation of innovation capacity, promote the research and development of innovative drugs, in order to gradually realize the global registered research and development capacity.

marketing

Company sales network spread widely, has formed a professional and efficient sales force to market agriculture, with the national and regional large pharmaceutical circulation enterprises to carry out the depth of cooperation, the terminal cover all levels of hospitals, health service centers, clinics, pharmacies, etc., comprehensive sales network and professional sales team for the company provided guarantee steady growth in sales scale.

Production

It has established independent and complete drug production, quality and pharmacovigilance systems, established quality system documents in line with drug production quality management standards, and implemented quality management elements such as quality risk management and change management throughout the drug life cycle. The drug production workshop is designed and built in accordance with the National Drug laws and regulations and the "Drug Production Quality Management Standard", and the production process conforms to the drug production quality management standard. All workshops have passed the national certification or conformity inspection.

Products and Markets

As the national innovative generic drug industrialization base, the company adheres to the strategic goal of successfully developing 100 new products in 10 years.